WHO confirms better clinical outcomes of telemedicine

A new study conducted by WHO/Europe and the Faculty of Health Sciences of the Open University of Catalonia (an approved WHO collaborator in digital health) shows that telemedicine technologies have clear benefits in detecting, diagnosing, managing, treating and monitoring chronic diseases in the European region, iSanidad reports (in Spanish).

Digital technologies were used to provide essential healthcare services during the Covid-19 pandemic. Telemedicine has already been considered a cost-effective and accessible method of providing high-quality care and reducing overall morbidity and mortality. Over 20,000 studies covering more than 20,000 patients from 53 countries were analyzed to get an overview of telemedicine in Europe and Central Asia.

The use of telemedicine resulted in better clinical conclusions and better follow-up by health professionals. As a result, patients will benefit.

“We found that the use of digital tools to deliver health services had a clear and significant effect on patients. We see better clinical outcomes, better follow-up by healthcare professionals, and an overall benefit for both patients and healthcare workers”, explains by Dr David Novillo-Ortiz, regional advisor on data and digital health and lead author of the study.

Related News

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner